Galderma has launched its next-generation skincare innovation, Regenerating Skin Nectar with TriHex+, under its Alastin brand. The company positions the product as an advanced peri-procedural skincare solution designed to enhance skin preparation and recovery around cosmetic treatments. The new launch builds on the original Regenerating Skin Nectar, which has been widely used in aesthetic dermatology for over a decade. Dermatologists ...
Galderma presents new scientific dermatology data at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, March 27–31. The company shares 22 abstracts, including late‑breaking data and oral presentations. These sessions span therapeutic dermatology and skin care science. Atopic dermatitis presentations include late-breaking data Galderma presents late‑breaking data on Nemluvio® (nemolizumab) for moderate‑to‑severe atopic dermatitis across different ...
Galderma launched “We Are All Sculptra”, showcasing Sculptra’s regenerative versatility across diverse patient demographics. The programme tracks nine treatment-naïve participants over two years. It delivers longitudinal insights into tailoring regenerative biostimulation across ages, skin types, ethnicities, and aesthetic goals. Through structured clinical documentation, standardised imaging, and patient-reported video diaries, the initiative provides real-world evidence of outcomes in routine practice settings. ...
Galderma released findings from a groundbreaking real-world study in China, showing how lifestyle and environmental factors directly affect sensitive skin. Galderma will present the results at the European Academy of Dermatology and Venereology (EADV) 2025 Congress. The findings highlight a direct biological link between modern urban living and worsening skin health. Rising prevalence of sensitive skin Sensitive skin affects up ...
Sensitive skin is now one of the most common skin concerns, affecting nearly 70 per cent of people worldwide. Sensitive skin cases have increased dramatically in 20 years, raising questions about the impact of modern lifestyles and environmental changes. Galderma has been actively studying this trend through its Global Sensitive Skin Faculty, which is a group of leading dermatology experts. ...
Galderma is stepping up to a growing challenge in aesthetic medicine: facial volume loss linked to medication-driven weight loss. As more patients experience these changes, both they and practitioners are looking for effective solutions. Recently, Galderma shared final results from a unique nine-month phase IV study. The study shows that combining Sculptra® with Restylane® Lyft™ or Contour™ leads to lasting ...
Galderma marks the 25th anniversary of Sculptra® with new data and recent approvals, strengthening its leadership in regenerative aesthetics. Sculptra has been used to enhance skin rejuvenation, thanks to its unique formulation of poly-L-lactic acid (PLLA-SCA™). It has helped millions of people worldwide restore their skin’s natural radiance by working in harmony with the body’s own processes. As one of ...
Cetaphil by Galderma India announced the launch of its latest innovation – Cetaphil Bright Healthy Radiance Range. The all-new range is in line with Cetaphil’s promise and expertise of ‘gentle skincare’, with the added benefits of an even skin tone with reduced dark spots. This range befits all skin types and is especially formulated with care to cater to those ...
Galderma announced that AKLIEF® has completed the European decentralised procedure which will result in approval by all involved European member states Galderma announced that AKLIEF® (trifarotene 50 mcg/g cream) has concluded its European decentralised procedure resulting in the approval of its summary of product characteristics, package leaflet, and labelling, by all involved European member states. Each of the 16 concerned ...